In various in vivo neurodegenerative models characterized by myelin loss (stroke, trauma, demyelination, and experimental autoimmune encephalomyelitis), Gpr17 was abnormally up-regulated in OPCs around lesion sites21,27,50. This evidence concerns the gene GPR17 and experimental autoimmune encephalomyelitis.